Clinical Trial Update: NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the NanoKnife Low Energy Direct Current (LEDC) System in locally advanced unresectable pancreatic cancer has completed. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• NanoKnife Low Energy Direct Current (LEDC) System

Snippet

Sponsor: Angiodynamics, Inc. | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED